Recent evidence has implicated endoglin, a TGFβ type III receptor and co-receptor, in cancer cell invasion in prostate cancer cell lines via activin A signaling, though endoglin has primarily been shown to propagate the signal by forming a complex with TGFβ and its receptors [99]. Here, ENG is linked to prostate carcinoma.